天美传媒

Abstract

This compilation highlights global progress and challenges in cervical cancer control, emphasizing HPV vaccination and screening effectiveness alongside persistent disparities, especially in low-resource settings. Innovations include risk-based screening guidelines, HPV self-sampling, and the emergence of immune checkpoint inhibitors for advanced cases. Molecular biomarkers and Artificial Intelligence (AI) offer promise for personalized diagnosis and treatment. However, the psychosocial burden on patients remains significant. The data collectively underscores the critical need for equitable access to integrated prevention, early detection, and advanced therapeutic strategies to achieve global elimination goals.